AR046592A1 - Preparacion de derivados de 3 - azabiciclo [ 3 . 1 . 0 ] hexano - Google Patents
Preparacion de derivados de 3 - azabiciclo [ 3 . 1 . 0 ] hexanoInfo
- Publication number
- AR046592A1 AR046592A1 ARP040103725A ARP040103725A AR046592A1 AR 046592 A1 AR046592 A1 AR 046592A1 AR P040103725 A ARP040103725 A AR P040103725A AR P040103725 A ARP040103725 A AR P040103725A AR 046592 A1 AR046592 A1 AR 046592A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- 4alkyl
- cycloalkyl
- compound
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Se refiere particularmente al uso de tales derivados para tratar determinados trastornos y afecciones, incluyendo, por ejemplo, el síndrome del intestino irritado, la drogadicción o la drogodependencia, la adición o la dependencia del alcohol, la depresión y los trastornos de la alimentación. Reivindicación 1: Un procedimiento para la preparación de un compuesto de fórmula (1), en el que X es halógeno, -OH, -CN, -alquilo C1-4 sustituido con uno a tres átomos de halógenos, -NH2, -NH(alquilo C1-4), -N(alquil C1-4)(alquilo C1-4), -C(=O)NH2, -C(=O)NH(alquilo C1-4), -C(=O)N(alquil C1-4)(alquilo C1-4), -NHS(=O2)H, o -NHS(=O)2R4; R1 y R2 están unidos, con el carbono al que se unen, para formar un cicloalquilo C3-7 o un heterocicloalquilo de 4- 7 miembros que comprende de uno a tres restos hetero seleccionados de O, S -C(=O) y N; y en el que dicho cicloalquilo o heterocicloalquilo contiene opcionalmente uno o dos dobles enlaces; y en el que dicho cicloalquilo o heterocicloalquilo está condensado o unido opcionalmente a un arilo C6-14 o a un grupo heteroarilo de 5-14 miembros; R3 es alquilo C1-4 que puede contener opcionalmente uno o dos enlaces insaturados, -OH, -CN, -NO2, -O-alquilo(C1-4), -NH2 amida o amida sustituida con alquilo; y n es uno o cero; R4 se selecciona de alquilo C1-4, -(alquilen C1-4)-O-(alquilo C1-4), 4-(1-metilimidazol), -(alquilen C1-4)-NH2, -(alquilen C1-4)-NH(alquilo C1-4), -(alquilen C1-4)-N(alquil C1-4)(alquilo C1-4), que comprende la reacción de un compuesto de fórmula (2), con un compuesto de fórmula (3), en presencia de un agente reductor y un disolvente orgánico.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51188903P | 2003-10-16 | 2003-10-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR046592A1 true AR046592A1 (es) | 2005-12-14 |
Family
ID=34465290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040103725A AR046592A1 (es) | 2003-10-16 | 2004-10-14 | Preparacion de derivados de 3 - azabiciclo [ 3 . 1 . 0 ] hexano |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7129263B2 (es) |
| EP (1) | EP1675829A1 (es) |
| JP (1) | JP2007508367A (es) |
| KR (1) | KR20060096038A (es) |
| CN (1) | CN1867548A (es) |
| AR (1) | AR046592A1 (es) |
| AU (1) | AU2004281229A1 (es) |
| BR (1) | BRPI0415459A (es) |
| CA (1) | CA2540860A1 (es) |
| CO (1) | CO5680416A2 (es) |
| IL (1) | IL174596A0 (es) |
| MX (1) | MXPA06004278A (es) |
| NO (1) | NO20062152L (es) |
| RU (1) | RU2006112576A (es) |
| TW (1) | TW200524866A (es) |
| WO (1) | WO2005037790A1 (es) |
| ZA (1) | ZA200601964B (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003296324A1 (en) | 2002-12-10 | 2004-06-30 | Wyeth | Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| JP4732354B2 (ja) * | 2003-10-14 | 2011-07-27 | ファイザー・プロダクツ・インク | グリシン輸送阻害薬としての二環式［３．１．０］誘導体 |
| WO2008075162A2 (en) * | 2006-12-15 | 2008-06-26 | Pfizer Limited | Selective mu opioid receptor antagonists for the treatment of female sexual dysfunction |
| WO2012042539A2 (en) | 2010-09-28 | 2012-04-05 | Panacea Biotec Ltd | Novel bicyclic compounds |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| CA2927527C (en) | 2013-11-20 | 2021-06-01 | Sanwa Kagaku Kenkyusho Co., Ltd. | Novel 3-azabicyclo[3.1.0]hexane derivative and use thereof as u-opioid receptor antagonist |
| MX2017014835A (es) * | 2015-05-20 | 2018-02-19 | Sanwa Kagaku Kenkyusho Co | Cristal de sal de derivado de 3-azabiciclo[3.1.0]hexano novedoso y usos medicionales del mismo. |
| CN111683530A (zh) * | 2018-03-05 | 2020-09-18 | 纳幕尔杜邦公司 | 用于制备某些介离子类杀虫剂的方法和中间体 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI244481B (en) * | 1998-12-23 | 2005-12-01 | Pfizer | 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| CA2463264C (en) * | 2001-10-22 | 2009-05-26 | Pfizer Products Inc. | 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
-
2004
- 2004-10-06 WO PCT/IB2004/003261 patent/WO2005037790A1/en not_active Application Discontinuation
- 2004-10-06 RU RU2006112576/04A patent/RU2006112576A/ru not_active Application Discontinuation
- 2004-10-06 AU AU2004281229A patent/AU2004281229A1/en not_active Abandoned
- 2004-10-06 BR BRPI0415459-2A patent/BRPI0415459A/pt not_active IP Right Cessation
- 2004-10-06 KR KR1020067007220A patent/KR20060096038A/ko not_active Application Discontinuation
- 2004-10-06 JP JP2006534849A patent/JP2007508367A/ja not_active Abandoned
- 2004-10-06 CN CNA2004800305305A patent/CN1867548A/zh active Pending
- 2004-10-06 EP EP04769571A patent/EP1675829A1/en not_active Withdrawn
- 2004-10-06 MX MXPA06004278A patent/MXPA06004278A/es not_active Application Discontinuation
- 2004-10-06 CA CA002540860A patent/CA2540860A1/en not_active Abandoned
- 2004-10-12 TW TW093130881A patent/TW200524866A/zh unknown
- 2004-10-14 AR ARP040103725A patent/AR046592A1/es not_active Application Discontinuation
- 2004-10-15 US US10/966,712 patent/US7129263B2/en not_active Expired - Fee Related
-
2006
- 2006-03-08 ZA ZA200601964A patent/ZA200601964B/en unknown
- 2006-03-27 IL IL174596A patent/IL174596A0/en unknown
- 2006-04-05 CO CO06033213A patent/CO5680416A2/es not_active Application Discontinuation
- 2006-05-12 NO NO20062152A patent/NO20062152L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO5680416A2 (es) | 2006-09-29 |
| RU2006112576A (ru) | 2006-08-27 |
| IL174596A0 (en) | 2006-08-20 |
| NO20062152L (no) | 2006-05-12 |
| JP2007508367A (ja) | 2007-04-05 |
| BRPI0415459A (pt) | 2006-12-19 |
| TW200524866A (en) | 2005-08-01 |
| US7129263B2 (en) | 2006-10-31 |
| EP1675829A1 (en) | 2006-07-05 |
| WO2005037790A1 (en) | 2005-04-28 |
| ZA200601964B (en) | 2007-04-25 |
| AU2004281229A1 (en) | 2005-04-28 |
| MXPA06004278A (es) | 2006-06-28 |
| CA2540860A1 (en) | 2005-04-28 |
| CN1867548A (zh) | 2006-11-22 |
| KR20060096038A (ko) | 2006-09-05 |
| US20050113437A1 (en) | 2005-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20081583A1 (es) | Agentes antibacterianos derivados de compuestos carbonilamino | |
| CO5680416A2 (es) | Preparacion de derivados de 3-azabiciclo [3,1,0]hexano | |
| PE20070069A1 (es) | Piperazin-piperidinas como antagonistas y agonistas del receptor 5-ht1a | |
| BR0112856A (pt) | Método para o tratamento dos distúrbios, composto ou um sal ou solvato deste, processo para a preparação dos mesmos, composição farmacêutico, método de tratamento e/ou profilaxia de um ou mais dos distúrbios, uso de um composto, e, método para o tratamento de diabetes, grande depressão, depressão manìaca, ansiedade, esquizofrenia e distúrbios do sono, em mamìferos humanos e não humanos | |
| CY1116520T1 (el) | Φαρμακοτεχνικη μορφη fulvestrant | |
| ECSP066992A (es) | ÁCIDO 2-{[2-(2-METILAMINOPIRIMIDIN-4-IL)-1H-INDOL-5-CARBONIL]AMINO}-3-(FENILPIRIDIN-2-ILAMINO)PROPIÓNICOSUSTANCIALMENTE PURO COMO INHIBIDOR DE LA CINASA IkB | |
| NO20034011D0 (no) | Steroider som agonister for FXR | |
| AR054127A1 (es) | Imidazoquinolinas como inhibidores de quinasa de lipido | |
| PE20070527A1 (es) | Derivados de espirocromanona como agentes inhibidores de la acetil coenzima a carboxilasa | |
| AR043938A1 (es) | Compuesto heterociclico derivado de quinolina o naftiridina, composicion farmaceutica que lo comprende y su uso para preparar esta ultima | |
| ATE495442T1 (de) | Zusammensetzungen und verfahren zur erkennung von sirolimus | |
| CO6150158A2 (es) | Piperidinas sustituidas que aumentan la actividad de p53 y su uso | |
| PE20070218A1 (es) | COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA | |
| ATE522507T1 (de) | Montelukast in fester phase | |
| AR056214A1 (es) | Inhibidores de la proteina que activa la 5- lipooxigenasa (flap) | |
| BRPI0408353A (pt) | composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto | |
| CO5680438A2 (es) | Uso de derivados de ciclotiocarbamato en tratamiento de condiciones relacionadas con hormonas | |
| HRP20120963T1 (hr) | PIRIDO-, PIRAZO- I PIRIMIDOPIRIMIDINSKI DERIVATI KAO mTOR INHIBITORI | |
| CY1112001T1 (el) | Μακροκυκλικοι αναστολεις του ιου της ηπατιτιδας c | |
| AR056338A1 (es) | Derivados hexahidroquinolina, composiciones farmaceuticas y su uso en el tratamiento de desordenes de fertilidad | |
| CO5680439A2 (es) | Derivados de ciclotiocarbamato como moduladores de pr y su uso para el tratamiento de desordenes de la piel | |
| HUP0401884A2 (hu) | Opioid receptor antagonista hatású 3-azabiciklo[3.1.0]hexán-származékok és ezeket tartalmazó gyógyszerkészítmények | |
| AR053109A1 (es) | DERIVADOS DE PIPERIDINA Y PIPERAZINA, UN METODO PARA SU PREPARACION, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y SU USO EN LA ELABORACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR EL RECEPTOR DE QUIMIOQUINA CCR2. | |
| BRPI0406500A (pt) | processo farmacêutico e compostos preparados pelo mesmo | |
| AR077301A1 (es) | Derivados de 2-carboxamida-7-piperazinil-benzofurano como antagonistas de 5-ht1a y 5-ht1b |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |